Nigeria

Resilience System


You are here

Analysis

What's next for COVID-19 apps? Governance and oversight

Science   Article 

Studies conducted in April and May 2020 showed that in countries like the United States, Switzerland, and Italy, between 55 and 70% of adults in all age groups were willing to download a contact tracing app (5).

Yet these figures do not match the current DCT apps uptake. Even in countries with robust privacy safeguards in place, downloads of DCT apps have been below expectations. At the time of writing, the Australian DCT app has been downloaded by 6.5 million (26% of the population), the Italian one by 8 million (13.4%), and the newly released French one by 1.5 million (2.3%). Ireland has about 1.3 million active app users (24%), Switzerland 1.8 million (21.5%), and Germany 16 million (19.3%).

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

British Study: Black people 'twice as likely to catch coronavirus'

Black people are twice as likely as white people to catch the coronavirus, a study of 18 million people suggests.

The research also indicates Asian people are 1.5 times more likely than white people to be infected - and may be more likely to need intensive care.

Problem, Solution, SitRep, or ?: 

New Airflow Videos Show Why Masks With Exhalation Valves Do Not Slow the Spread of COVID-19New Airflow Videos Show Why Masks With Exhalation Valves Do Not Slow the Spread of COVID-19

Many people wear masks in public to slow the spread of COVID-19, as recommended by the Centers for Disease Control and Prevention (CDC). However, masks with exhalation valves do not slow the spread of the disease, and now, new videos from the National Institute of Standards and Technology (NIST) show why. 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Can a nose-full of chicken antibodies ward off coronavirus infections?

While the world waits for a widely available, safe, and effective COVID-19 vaccine, scientists are becoming ever more creative in their search for other ways to protect people from the disease. Now, a clinical trial has begun in Australia to find out whether nasal drops that contain chicken antibodies to SARS-CoV-2 can offer temporary protection.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Analysis
howdy folks
Page loaded in 0.747 seconds.